Literature DB >> 23874018

Physiologic and pathophysiologic roles of cyclooxygenase-2 in the kidney.

Raymond C Harris1.   

Abstract

In the mammalian kidney, prostaglandins are important mediators of physiologic processes, including modulation of vascular tone and salt and water. Prostaglandins arise from enzymatic metabolism of free arachidonic acid (AA), which is cleaved from membrane phospholipids by phospholipase A2 activity. The cyclooxygenase (COX) enzyme system is a major pathway for metabolism of arachidonic acid in the kidney. Cyclooxygenases are the enzymes responsible for the initial conversion of AA to PGG2 and subsequently to PGH2, which serves as the precursor for subsequent metabolism by specific prostaglandin and thromboxane synthases. In addition to high levels of expression of the "constitutive" rate-limiting enzyme responsible for prostanoid production, COX-1, the "inducible" isoform of cyclooxygenase, COX-2, is also constitutively expressed in the kidney and is highly regulated in response to alterations in intravascular volume. Prostaglandins and thromboxane A2 exert their biological functions predominantly through activation of specific 7-transmembrane G-protein-coupled receptors. We and others have shown that COX-2-derived prostaglandins exert important physiologic functions in maintenance of renal blood flow, mediation of renin release, and regulation of sodium excretion. In addition to physiologic regulation of prostanoid production in the kidney, increases in prostanoid production are also observed in a variety of inflammatory renal injuries, and we have found a role for COX metabolites to serve as mediators of inflammatory injury in renal disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23874018      PMCID: PMC3715909     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  66 in total

Review 1.  Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics.

Authors:  A Whelton
Journal:  Am J Ther       Date:  2000-03       Impact factor: 2.688

2.  Low sodium and furosemide-induced stimulation of the renin system in man is mediated by cyclooxygenase 2.

Authors:  M C Kammerl; R M Nüsing; F Schweda; D Endemann; M Stubanus; F Kees; K J Lackner; M Fischereder; B K Krämer
Journal:  Clin Pharmacol Ther       Date:  2001-11       Impact factor: 6.875

3.  Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition.

Authors:  K Athirakul; H S Kim; L P Audoly; O Smithies; T M Coffman
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

4.  Furosemide stimulates macula densa cyclooxygenase-2 expression in rats.

Authors:  B Mann; A Hartner; B L Jensen; M Kammerl; B K Krämer; A Kurtz
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

5.  Low chloride stimulation of prostaglandin E2 release and cyclooxygenase-2 expression in a mouse macula densa cell line.

Authors:  T Yang; J M Park; L Arend; Y Huang; R Topaloglu; A Pasumarthy; H Praetorius; K Spring; J P Briggs; J Schnermann
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

6.  Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition.

Authors:  H F Cheng; J L Wang; M Z Zhang; S W Wang; J A McKanna; R C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2001-03

7.  Cyclo-oxygenase-2 inhibition increases blood pressure in rats.

Authors:  Klaus Höcherl; Dierk Endemann; Martin C Kammerl; Horst F Grobecker; Armin Kurtz
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

8.  Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.

Authors:  Zhonghua Qi; Chuan-Ming Hao; Robert I Langenbach; Richard M Breyer; Reyadh Redha; Jason D Morrow; Matthew D Breyer
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 9.  Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct.

Authors:  James A Schafer
Journal:  Am J Physiol Renal Physiol       Date:  2002-08

10.  Prostaglandins that increase renin production in response to ACE inhibition are not derived from cyclooxygenase-1.

Authors:  Hui-Fang Cheng; Sue-Wan Wang; Ming-Zhi Zhang; James A McKanna; Richard Breyer; Raymond C Harris
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-09       Impact factor: 3.619

View more
  14 in total

1.  Bone marrow-derived cPLA2α contributes to renal fibrosis progression.

Authors:  John R Montford; Allison M B Lehman; Colin D Bauer; Jelena Klawitter; Jost Klawitter; Joanna M Poczobutt; Micah Scobey; Mary Weiser-Evans; Raphael A Nemenoff; Seth B Furgeson
Journal:  J Lipid Res       Date:  2017-12-11       Impact factor: 5.922

2.  Differential compensation of two cyclooxygenases in renal homeostasis is independent of prostaglandin-synthetic capacity under basal conditions.

Authors:  Xinzhi Li; Liudmila L Mazaleuskaya; Laurel L Ballantyne; Hu Meng; Garret A FitzGerald; Colin D Funk
Journal:  FASEB J       Date:  2018-04-20       Impact factor: 5.191

3.  Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial.

Authors:  Kevan R Polkinghorne; James B Wetmore; Le Thi Phuong Thao; Rory Wolfe; Robyn L Woods; Michael E Ernst; Mark R Nelson; Christopher M Reid; Raj C Shah; John J McNeil; Anne M Murray
Journal:  Am J Kidney Dis       Date:  2022-04-14       Impact factor: 11.072

Review 4.  Regulation and function of renal medullary cyclooxygenase-2 during high salt loading.

Authors:  Tianxin Yang; Mi Liu
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

Review 5.  Pharmacological strategies to prevent contrast-induced acute kidney injury.

Authors:  Pattharawin Pattharanitima; Adis Tasanarong
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

6.  A maladaptive role for EP4 receptors in mouse mesangial cells.

Authors:  Guang-xia Yang; Yu-yin Xu; Ya-ping Fan; Jing Wang; Xiao-lan Chen; Yi-de Zhang; Jian-hua Wu
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

7.  Acetylsalicylic acid interferes with embryonic kidney growth and development by a prostaglandin-independent mechanism.

Authors:  Simon J M Welham; Alexander J Sparrow; David S Gardner; Matthew J Elmes
Journal:  World J Nephrol       Date:  2017-01-06

8.  Multitarget molecule, PTUPB, to treat diabetic nephropathy in rats.

Authors:  Md Abdul Hye Khan; Sung Hee Hwang; Scott D Barnett; Anna Stavniichuk; Wojciech K Jankiewicz; Bruce D Hammock; John D Imig
Journal:  Br J Pharmacol       Date:  2021-08-12       Impact factor: 8.739

9.  Group V Secretory Phospholipase A2 Is Involved in Tubular Integrity and Sodium Handling in the Kidney.

Authors:  João Luiz Silva-Filho; Diogo Barros Peruchetti; Felipe Moraes-Santos; Sharon Schilling Landgraf; Leandro Souza Silva; Gabriela Modenesi Sirtoli; Daniel Zamith-Miranda; Christina Maeda Takiya; Ana Acacia Sá Pinheiro; Bruno Lourenço Diaz; Celso Caruso-Neves
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

10.  Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs.

Authors:  Blerina Ahmetaj-Shala; Nicholas S Kirkby; Rebecca Knowles; Malak Al'Yamani; Sarah Mazi; Zhen Wang; Arthur T Tucker; Louise Mackenzie; Paul C J Armstrong; Rolf M Nüsing; James A P Tomlinson; Timothy D Warner; James Leiper; Jane A Mitchell
Journal:  Circulation       Date:  2014-12-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.